Assess Perioperative Infection Risk for Immunosuppressants and Biologics

September 2019

You'll be asked whether immunosuppressants and biologics need to be held around elective surgeries to reduce infection or healing risks.

The concern is that stopping them could lead to disease flares.

Work with surgery during your peri-op process. But expect to consult closely with rheumatology, GI, or another specialist...since evidence is limited.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Learn More

Already a subscriber? Log in

Not sold to individuals

Immunology Implement Strategies to Tackle the IVIG Shortage
Hazardous Meds Be Prepared to Answer Questions About Hazardous Meds and USP 800
Pneumonia Don't Automatically Add Empiric Anaerobic Coverage for Aspiration Pneumonia
Surgery Assess Perioperative Infection Risk for Immunosuppressants and Biologics
Heart Failure Reserve Inotropes for Select Cases of Acute or End-Stage Heart Failure
Vaccines Anticipate Changes for the Use of Prevnar 13 in Seniors
Kidney Disease Be Aware of Nuances When Using Phosphate Binders
HIV & AIDS Stop MAC Prophylaxis in Some HIV Patients
Anticholinergics Put the Dementia Link With Anticholinergics in Perspective
Osteoporosis Be Prepared if Your Infusion Center Gives Romosozumab (Evenity) for Osteoporosis

Assess Perioperative Infection Risk for Immunosuppressants and Biologics

Get unlimited access through an Enterprise license

Table of Contents